Tela Bio Inc (TELA) Stock Price, Quote & News

Company Profile

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex...

Industry: Medical Devices

Sector: Healthcare

Phone: 484 320 2930

Website: www.telabio.com

Address:

1 Great Valley Parkway, Suite 24, Malvern, United States

Dr_Monkeybreath Apr. 2 at 1:42 PM

$TELA 10,000 @ .639.🔒

0 · Reply

KylaGPS10x Apr. 2 at 12:39 AM

$TELA 27 million market cap and 100 million in sales a good company will be more than willing to buy TELA for 2x sales or 200 million just buy shares every chance you get now

0 · Reply

Dr_Monkeybreath Mar. 31 at 3:56 PM

$TELA 7,700 @ .667. keep it cheap!👍

0 · Reply

Dr_Monkeybreath Mar. 31 at 2:34 PM

$TELA payday! 5,000 @ .692.🔒money for more and really want some .50's.🍽️

0 · Reply

Bears2354 Mar. 30 at 8:03 PM

$TELA ouch all bad

1 · Reply

m_moon Mar. 30 at 7:56 PM

$TOP news ?? Lets go $TELA $100 again 😂 $BTC.X

0 · Reply

Dr_Monkeybreath Mar. 26 at 1:39 PM

$TELA wow. moves on nothing. sorry i missed the cheaper shares but also glad i didn't sell. surprised more people aren't on this. 💎

0 · Reply

erevnon Mar. 25 at 7:49 PM

Piper Sandler maintains TELA Bio $TELA at Neutral and lowers the price target from $1.25 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

KylaGPS10x Mar. 25 at 1:39 PM

$TELA decent earnings nice path forward we should see $2 plus this year pretty good investment at this price

0 · Reply

Wisenheimer Mar. 24 at 9:38 PM

$TELA continues to subsidize sales w losses but now Perceptive basically owns the co at a 12% rate 70m sr secured debt - 9m loss in qtr hasnt changed since last qtr with higher sales. How will they ever pay off the loan. Equity holders will continue to be last in this.

0 · Reply

TELA Bio Analysts Cut Their Forecasts After Q4 Results

Mar 24, 2026, 4:05 PM EDT - 14 days ago

TELA Bio Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 10, 2026, 4:05 PM EDT - 4 weeks ago

TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results

Feb 20, 2026, 4:05 PM EST - 6 weeks ago

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nov 19, 2025, 8:30 AM EST - 4 months ago

TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 14, 2025, 11:42 AM EST - 5 months ago

These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings

Nov 13, 2025, 4:21 PM EST - 5 months ago

TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants

Nov 13, 2025, 4:01 PM EST - 5 months ago

TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility

Oct 9, 2025, 4:05 PM EDT - 6 months ago

TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran

Aug 11, 2025, 4:03 PM EDT - 8 months ago

TELA Bio Reports Second Quarter 2025 Financial Results

Jul 23, 2025, 4:03 PM EDT - 9 months ago

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

Jul 21, 2025, 4:03 PM EDT - 9 months ago

TELA Bio to Announce Second Quarter 2025 Financial Results

Jun 6, 2025, 4:05 PM EDT - 10 months ago

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 3, 2025, 4:05 PM EDT - 11 months ago

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

Jun 2, 2025, 8:30 AM EDT - 11 months ago

TELA Bio Appoints Jeffrey Blizard as President

May 22, 2025, 4:05 PM EDT - 11 months ago

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

Apr 17, 2025, 4:05 PM EDT - 1 year ago

TELA Bio to Announce First Quarter 2025 Financial Results

Mar 20, 2025, 4:05 PM EDT - 1 year ago

TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results

Nov 19, 2024, 4:05 PM EST - 1 year ago

TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference

Oct 24, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Oct 23, 2024, 8:07 AM EDT - 1 year ago

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Oct 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Oct 17, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Third Quarter 2024 Financial Results

Aug 12, 2024, 4:05 PM EDT - 1 year ago

TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance

Jul 22, 2024, 4:05 PM EDT - 1 year ago

TELA Bio to Announce Second Quarter 2024 Financial Results

Jun 4, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Appoints Jeffrey Blizard to its Board of Directors

May 20, 2024, 4:03 PM EDT - 2 years ago

TELA Bio Appoints Greg Firestone as Chief Commercial Officer

May 9, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Reports First Quarter 2024 Financial Results

Apr 25, 2024, 7:00 AM EDT - 2 years ago

TELA Bio to Announce First Quarter 2024 Financial Results

Apr 15, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures

Apr 8, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy

Mar 21, 2024, 4:05 PM EDT - 2 years ago

TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results

Mar 21, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery

Mar 20, 2024, 7:00 AM EDT - 2 years ago

TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX

Feb 29, 2024, 7:00 AM EST - 2 years ago

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Dec 5, 2023, 7:00 AM EST - 2 years ago

TELA Bio to Take Part in Connecting the Dots

Nov 16, 2023, 7:00 AM EST - 2 years ago

TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference

Nov 9, 2023, 4:05 PM EST - 2 years ago

TELA Bio Reports Third Quarter 2023 Financial Results

Oct 26, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce Third Quarter 2023 Financial Results

Sep 18, 2023, 4:05 PM EDT - 2 years ago

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

Aug 16, 2023, 7:00 AM EDT - 2 years ago

TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

Aug 9, 2023, 4:03 PM EDT - 2 years ago

TELA Bio Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 7:00 AM EDT - 2 years ago

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

Jun 15, 2023, 7:00 AM EDT - 3 years ago

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

May 25, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Participate in the Jefferies Global Healthcare Conference

May 19, 2023, 7:00 AM EDT - 3 years ago

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

May 11, 2023, 4:02 PM EDT - 3 years ago

TELA Bio Reports First Quarter 2023 Financial Results

May 9, 2023, 7:00 AM EDT - 3 years ago

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

May 2, 2023, 7:00 AM EDT - 3 years ago

TELA Bio to Participate in the JMP Securities Life Sciences Conference

Dr_Monkeybreath Apr. 2 at 1:42 PM

$TELA 10,000 @ .639.🔒

0 · Reply

KylaGPS10x Apr. 2 at 12:39 AM

$TELA 27 million market cap and 100 million in sales a good company will be more than willing to buy TELA for 2x sales or 200 million just buy shares every chance you get now

0 · Reply

Dr_Monkeybreath Mar. 31 at 3:56 PM

$TELA 7,700 @ .667. keep it cheap!👍

0 · Reply

Dr_Monkeybreath Mar. 31 at 2:34 PM

$TELA payday! 5,000 @ .692.🔒money for more and really want some .50's.🍽️

0 · Reply

Bears2354 Mar. 30 at 8:03 PM

$TELA ouch all bad

1 · Reply

m_moon Mar. 30 at 7:56 PM

$TOP news ?? Lets go $TELA $100 again 😂 $BTC.X

0 · Reply

Dr_Monkeybreath Mar. 26 at 1:39 PM

$TELA wow. moves on nothing. sorry i missed the cheaper shares but also glad i didn't sell. surprised more people aren't on this. 💎

0 · Reply

erevnon Mar. 25 at 7:49 PM

Piper Sandler maintains TELA Bio $TELA at Neutral and lowers the price target from $1.25 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

KylaGPS10x Mar. 25 at 1:39 PM

$TELA decent earnings nice path forward we should see $2 plus this year pretty good investment at this price

0 · Reply

Wisenheimer Mar. 24 at 9:38 PM

0 · Reply

tradepulsealerts Mar. 24 at 8:50 PM

$TELA mesh is too thick

0 · Reply

StocktwitsEarnings Mar. 24 at 8:10 PM

$TELA Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.17 up 26.09% YoY • Reported revenue of $20.87M up 18.24% YoY • TELA Bio expects full year 2026 revenue growth of at least 8% over full year 2025, with first quarter 2026 revenue projected to be approximately $18.5M.

0 · Reply

Dr_Monkeybreath Mar. 18 at 5:11 PM

$TELA make that 3,333 @ .7335.👍

0 · Reply

Dr_Monkeybreath Mar. 18 at 4:07 PM

$TELA 1,800 @ .747.🔒

0 · Reply

KylaGPS10x Mar. 4 at 2:22 PM

$TELA over 70 percent institutional owned any hint of turn around with the new sales force and this rockets towards $3-$5

0 · Reply

OfficialStocktwitsUser Mar. 4 at 2:38 AM

$TELA RSI: 51.29, MACD: -0.0338 Vol: 0.04, MA20: 0.81, MA50: 0.96 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Bears2354 Mar. 2 at 3:46 PM

$TELA

0 · Reply

KylaGPS10x Feb. 24 at 6:11 PM

$TELA company is a screaming buy u der a dollar. Once the new sales team gets to work the sales will increase 2-3 fold

0 · Reply

BillionerOfKing Feb. 23 at 12:10 PM

$TELA Current Stock Price: $0.72 Contracts to trade: $2.5 TELA Mar 20 2026 Call Entry: $0.05 Exit: $0.06 ROI: 31% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Bears2354 Feb. 19 at 9:17 PM

$TELA nice bullish 1 month pendent. Should take off soon. And he out of this sub $1

0 · Reply

LisaShiroma238 Feb. 18 at 1:47 PM

$TELA Medical device company with reimbursement risk.

0 · Reply

KylaGPS10x Feb. 17 at 1:54 PM

$TELA revenue of 100 million should be trading at 2-3x sales this will go to $3 this year

0 · Reply

Market Cap	28.19M
Revenue (ttm)	80.28M
Net Income (ttm)	-38.83M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-48.37%
Debt to Equity Ratio	8.82

Volume	238,200
Avg Vol	229,336
Day's Range	N/A - N/A
Shares Out	44.74M
Stochastic %K	59%
Beta	0.99
Analysts	Strong Sell
Price Target	$2.25